European Stocks Close Slightly Higher

European stocks closed slightly higher as investors digested the ECB's expected 25 bps rate cut, which was accompanied by signals of a potential pause in further easing after inflation hit its 2% target. Sector performance was mixed, with Wise Plc gaining over 7% on plans to move its primary listing to New York, while Wizz Air Holdings plummeted nearly 28% after reporting a 62% slide in annual operating profit; economic data released during the session painted a mixed picture of the Eurozone and UK economies.

Analysis

European equity markets exhibited a marginal upward trend, with the pan-European Stoxx 600 advancing 0.16%, as investors processed the European Central Bank's widely anticipated 25 basis point reduction in key interest rates. This cut brought the main refinancing operations rate to 2.15%, the marginal lending facility rate to 2.4%, and the deposit facility rate to 2.0%. However, ECB President Christine Lagarde's commentary, suggesting the central bank is in a "good position" now that inflation has reached its 2% target, was interpreted as a signal for a potential pause in its year-long easing cycle, tempering expectations for further immediate cuts. Market sentiment was also shaped by ongoing assessment of potential impacts from Trump Administration tariff policies on global trade and growth. Performance across major national indices was mixed: the UK's FTSE 100 rose 0.11% and Germany's DAX gained 0.19%, while France's CAC 40 declined 0.18%.

Significant company-specific news drove notable stock movements. Wise Plc shares surged over 7% following its announcement to shift its primary listing from London to New York. Conversely, Wizz Air Holdings experienced a dramatic 28% plunge after reporting a 62% decrease in annual operating profit, attributed to growth challenges and capacity constraints. In the commodities sector, Antofagasta and Fresnillo saw strong gains of 5.3% and 5%, respectively. Bayer shares climbed nearly 4.5%, buoyed by a rating upgrade from 'neutral' to 'buy' by Goldman Sachs and USFDA approval for expanded use of its prostate cancer drug Nubeqa. In contrast, Pernod Ricard shares fell by approximately 5%.

Economic data presented a heterogeneous picture across the Eurozone and the UK. Eurozone producer prices decreased 2.2% month-on-month in April, a faster decline than March's 1.7%. The HCOB Germany Construction PMI indicated a slightly faster contraction in May, slipping to 44.4 from 45.1. However, German factory orders rose 0.6% month-on-month in April, marking a second consecutive monthly increase, albeit slower than March's revised 3.4% rise, and significantly outperformed forecasts of a 1% fall; on a yearly basis, factory orders expanded 4.8%. France's HCOB Construction PMI also worsened, falling to 43.1 in May, signaling a steeper contraction and extending the downturn into its third year. In the UK, revised data showed April's annual consumer price inflation was 3.4%, down from the initially reported 3.5%. The UK construction sector contracted at a slower pace in May, with the S&P Global PMI rising to 47.9, and the UK car market returned to growth with a 1.6% year-on-year increase in registrations, aided by EV demand.

Key Decisions for Investors

• Acknowledge the ECB's rate cut as a supportive measure but remain vigilant for signals of a protracted pause in the easing cycle, which could temper enthusiasm for rate-sensitive sectors.
• Focus on diligent stock selection, as company-specific catalysts, evidenced by Wise Plc's (+7%) relisting plans and Wizz Air's (-28%) profit slump, are driving significant performance disparities.
• Closely monitor the impact of potential U.S. tariffs and the mixed European economic data, particularly the persistent weakness in construction PMIs versus the relative resilience in German factory orders, for shifts in macroeconomic sentiment.
• Consider positive catalysts for specific names like Bayer, which benefited from a Goldman Sachs upgrade and FDA drug approval, while exercising caution with companies showing negative earnings revisions or those in sectors facing headwinds, such as Pernod Ricard.